Requesting that the FDA permit the filing of an Abbreviated New Drug Application for a proposed drug product that has the same active ingredient, same strength, and is expected to have the same therapeutic effect as Approved Drug Products with Therapeutic Equivalence Evaluations; CLOSED
🏛 Food and Drug Administration (FDA)FDA-2019-P-3022
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.